Skip to main content
logo
Adaptimmune Therapeutics plc (MUN:473A)
Germany flag Germany · Delayed Price · Currency is EUR
0.0125
0.00 (0.00%)
Last updated: May 21, 2026, 8:08 AM CEST

Adaptimmune Therapeutics Revenue

In the year 2025, Adaptimmune Therapeutics had annual revenue of $5.92M USD. Adaptimmune Therapeutics had revenue of $13.68M in the quarter ending June 30, 2025, a decrease of -89.33%.

Revenue
$5.92M
Revenue Growth
-96.62%
P/S Ratio
1.35
Revenue / Employee
$21.78K
Employees
272
Market Cap
6.82M EUR

Revenue Chart

Chart
* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20255.92M--
Dec 31, 2024---
Dec 31, 202360.28M33.13M122.05%
Dec 31, 202227.15M21.00M341.50%
Dec 31, 20216.15M2.19M55.36%
Dec 31, 20203.96M2.84M252.76%
Dec 31, 20191.12M-58.38M-98.11%
Dec 31, 201859.51M21.67M57.28%
Dec 31, 201737.83M23.64M166.47%
Dec 31, 201614.20M5.22M58.12%
Dec 31, 20158.98M-892.00K-9.04%
Jun 30, 20159.87M9.05M1,096.48%
Jun 30, 2014825.00K--
Jun 30, 2013---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Bayer Aktiengesellschaft45.38B
Fresenius SE & Co. KGaA23.28B
Siemens Healthineers AG23.17B
Merck KGaA21.14B
Maternus-Kliniken Aktiengesellschaft119.35M
Biofrontera AG15.97M
MeVis Medical Solutions AG15.48M
SynBiotic SE14.86M
Revenue Rankings

Adaptimmune Therapeutics News

More News